US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
GB9216082D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Univ Nottingham |
Lymphatic delivery composition
|
US5871710A
(en)
*
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
GB9406094D0
(en)
*
|
1994-03-28 |
1994-05-18 |
Univ Nottingham And University |
Polymer microspheres and a method of production thereof
|
US6007845A
(en)
*
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6040295A
(en)
|
1995-01-13 |
2000-03-21 |
Genemedicine, Inc. |
Formulated nucleic acid compositions and methods of administering the same for gene therapy
|
US5612052A
(en)
*
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
KR0180334B1
(en)
*
|
1995-09-21 |
1999-03-20 |
김윤 |
Drug messenger using el-2l-2 micelle and method for sealing drug to it
|
US5834025A
(en)
*
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
EP0862419B2
(en)
†
|
1995-11-09 |
2010-11-17 |
Microbiological Research Authority |
Microencapsulated dna for vaccination and gene therapy
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US5985312A
(en)
*
|
1996-01-26 |
1999-11-16 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
AU721209B2
(en)
*
|
1996-03-05 |
2000-06-29 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
AU736301B2
(en)
|
1996-05-01 |
2001-07-26 |
Imarx Therapeutics, Inc. |
Methods for delivering compounds into a cell
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
ATE366588T1
(en)
|
1996-09-11 |
2007-08-15 |
Imarx Pharmaceutical Corp |
METHOD FOR DIAGNOSTIC IMAGING OF THE KIDNEY REGION USING A CONTRAST AGENT AND A VASODILATOR
|
US6264917B1
(en)
|
1996-10-28 |
2001-07-24 |
Nycomed Imaging As |
Targeted ultrasound contrast agents
|
US6261537B1
(en)
|
1996-10-28 |
2001-07-17 |
Nycomed Imaging As |
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
|
WO1998018498A2
(en)
*
|
1996-10-28 |
1998-05-07 |
Marsden, John, Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
US6331289B1
(en)
|
1996-10-28 |
2001-12-18 |
Nycomed Imaging As |
Targeted diagnostic/therapeutic agents having more than one different vectors
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
AU739919B2
(en)
*
|
1997-04-30 |
2001-10-25 |
Point Biomedical Corporation |
Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
|
US20020159951A1
(en)
*
|
1997-05-06 |
2002-10-31 |
Unger Evan C. |
Novel targeted compositions for diagnostic and therapeutic use
|
US20020039594A1
(en)
*
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6275726B1
(en)
*
|
1997-05-15 |
2001-08-14 |
Board Of Regents, The University Of Texas System |
Methods of enhanced light transmission through turbid biological media
|
US6045777A
(en)
*
|
1997-06-30 |
2000-04-04 |
Acusphere, Inc. |
Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases
|
US6165440A
(en)
*
|
1997-07-09 |
2000-12-26 |
Board Of Regents, The University Of Texas System |
Radiation and nanoparticles for enhancement of drug delivery in solid tumors
|
US6211249B1
(en)
*
|
1997-07-11 |
2001-04-03 |
Life Medical Sciences, Inc. |
Polyester polyether block copolymers
|
US6287558B1
(en)
|
1997-08-01 |
2001-09-11 |
Biohybrio Technologies Llc |
Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
WO1999029759A1
(en)
*
|
1997-12-12 |
1999-06-17 |
Macromed, Inc. |
Heterofunctionalized star-shaped poly(ethylene glycols) for protein modification
|
US6254890B1
(en)
*
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
DE19813174A1
(en)
*
|
1998-03-25 |
1999-05-27 |
Schering Ag |
Gas-filled microparticles, used for administering biologically active substances
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
KR19990085365A
(en)
*
|
1998-05-16 |
1999-12-06 |
허영섭 |
Biodegradable polymer microspheres capable of continuously controlled controlled release and preparation method thereof
|
KR20010052368A
(en)
*
|
1998-05-20 |
2001-06-25 |
질레스피 카롤 |
Novel particulate formulations
|
KR100635456B1
(en)
|
1998-05-29 |
2006-10-18 |
스키에파마 캐나다 인코포레이티드 |
Thermoprotected Microparticle Compositions and Process for Terminal Steam Sterilization thereof
|
GB9814507D0
(en)
*
|
1998-07-03 |
1998-09-02 |
Univ Southampton |
A method and apparatus for controlling pests
|
US7343710B2
(en)
*
|
1998-07-03 |
2008-03-18 |
I.D.A Limited |
Method and apparatus for controlling pests
|
ATE502670T1
(en)
*
|
1998-08-14 |
2011-04-15 |
Incept Llc |
APPARATUS FOR IN-SITU FORMATION OF HYDROGELS
|
US6179862B1
(en)
|
1998-08-14 |
2001-01-30 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
WO2000029206A1
(en)
*
|
1998-11-13 |
2000-05-25 |
Sensor Technologies Inc. |
Monodisperse preparations useful with implanted devices
|
EP1133281A1
(en)
|
1998-11-20 |
2001-09-19 |
RTP Pharma Inc. |
Dispersible phospholipid stabilized microparticles
|
US6365173B1
(en)
|
1999-01-14 |
2002-04-02 |
Efrat Biopolymers Ltd. |
Stereocomplex polymeric carriers for drug delivery
|
US6045826A
(en)
*
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
DE19921088C2
(en)
*
|
1999-04-30 |
2003-08-07 |
Magforce Applic Gmbh |
Stent to keep aisle-like structures open
|
US8383081B2
(en)
*
|
1999-05-10 |
2013-02-26 |
Immunomedics, Inc. |
Anti-CD74 immunoconjugates and methods of use
|
US7829064B2
(en)
|
1999-05-10 |
2010-11-09 |
Immunomedics, Inc. |
Anti-CD74 immunoconjugates and methods
|
US8119101B2
(en)
*
|
1999-05-10 |
2012-02-21 |
The Ohio State University |
Anti-CD74 immunoconjugates and methods of use
|
US6426145B1
(en)
|
1999-05-20 |
2002-07-30 |
Scimed Life Systems, Inc. |
Radiopaque compositions for visualization of medical devices
|
AU5218500A
(en)
*
|
1999-06-22 |
2001-01-09 |
Aventis Research & Technologies Gmbh & Co. Kg |
Stable, radioactively marked nanoparticles, method for the production and utilization thereof
|
DE19930729A1
(en)
*
|
1999-07-05 |
2001-01-11 |
Achim Goepferich |
Block copolymers for the production of biomimetic surfaces
|
AU6636000A
(en)
|
1999-08-13 |
2001-03-13 |
Point Biomedical Corporation |
Hollow microspheres with controlled fragility for medical use
|
AU6635900A
(en)
*
|
1999-08-13 |
2001-03-13 |
Point Biomedical Corporation |
Microparticles useful as ultrasonic contrast agents and for lymphatic system
|
US20020041898A1
(en)
*
|
2000-01-05 |
2002-04-11 |
Unger Evan C. |
Novel targeted delivery systems for bioactive agents
|
WO2001069245A2
(en)
*
|
2000-03-14 |
2001-09-20 |
Trustees Of Tufts College |
Cross-reactive sensors
|
FR2809112B1
(en)
*
|
2000-05-16 |
2004-05-07 |
Centre Nat Rech Scient |
MATERIALS BASED ON BIODEGRADABLE POLYMERS AND PREPARATION METHOD THEREOF
|
AU2002225878A1
(en)
*
|
2000-11-02 |
2002-05-15 |
Smith Kline Beecham Corporation |
Receptor antagonist-lipid conjugates and delivery vehicles containing same
|
WO2002040874A1
(en)
|
2000-11-16 |
2002-05-23 |
California Institute Of Technology |
Apparatus and methods for conducting assays and high throughput screening
|
US6495154B1
(en)
*
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6607784B2
(en)
*
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20020142304A1
(en)
*
|
2001-03-09 |
2002-10-03 |
Anderson Daniel G. |
Uses and methods of making microarrays of polymeric biomaterials
|
US8137699B2
(en)
*
|
2002-03-29 |
2012-03-20 |
Trustees Of Princeton University |
Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
KR100463167B1
(en)
*
|
2001-04-13 |
2004-12-23 |
주식회사 태평양 |
Percutaneous Controlled Releasing Material Using Nano-sized Polymeric Particles and External Application Agent Containing the Same
|
US7153703B2
(en)
*
|
2001-05-14 |
2006-12-26 |
Board Of Trustees Of The University Of Arkansas N. A. |
Synthesis of stable colloidal nanocrystals using organic dendrons
|
AP1763A
(en)
|
2001-05-21 |
2007-08-02 |
Nektar Therapeutics |
Pulmonary administration of chemically modified insulin
|
AU2002320058A1
(en)
*
|
2001-06-06 |
2002-12-16 |
The General Hspital Corporation |
Magnetic-nanoparticle conjugates and methods of use
|
EP1406493A4
(en)
*
|
2001-06-11 |
2006-06-14 |
Xenoport Inc |
Administration of agents via the pept-2 transporter
|
DE60237449D1
(en)
*
|
2001-06-22 |
2010-10-07 |
Univ Johns Hopkins Med |
AMMENTS AND RELATED USES
|
US7498045B2
(en)
*
|
2001-08-31 |
2009-03-03 |
Thomas M. S. Chang |
Biodegradable polymeric nanocapsules and uses thereof
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
IL160570A0
(en)
|
2001-09-26 |
2004-07-25 |
Baxter Int |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
DE60222007T2
(en)
*
|
2001-10-18 |
2008-05-15 |
Samyang Corp. |
POLYMERMICELLA COMPOSITION WITH IMPROVED STABILITY
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
IL162183A0
(en)
*
|
2001-12-21 |
2005-11-20 |
Celator Technologies Inc |
Polymer-lipid delivery vehicles and methods for the preparation thereof
|
US9770517B2
(en)
|
2002-03-01 |
2017-09-26 |
Immunomedics, Inc. |
Anti-Trop-2 antibody-drug conjugates and uses thereof
|
AU2003224808A1
(en)
*
|
2002-03-28 |
2003-10-13 |
Imcor Pharmaceutical Company |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US6919068B2
(en)
*
|
2002-05-17 |
2005-07-19 |
Point Biomedical Corporation |
Method of preparing gas-filled polymer matrix microparticles useful for echographic imaging
|
US7670623B2
(en)
|
2002-05-31 |
2010-03-02 |
Materials Modification, Inc. |
Hemostatic composition
|
ES2601143T3
(en)
*
|
2002-07-19 |
2017-02-14 |
Omeros Corporation |
Biodegradable triblock copolymers, synthesis methods thereof, and hydrogels and biomaterials prepared therefrom.
|
FR2842737B1
(en)
*
|
2002-07-25 |
2006-01-27 |
Centre Nat Rech Scient |
PARTICLES COATED ON THE SURFACE OF HYALURONANE OR ONE OF ITS DERIVATIVES AND THEIR USE AS BIOLOGICAL VECTORS FOR ACTIVE MATERIALS
|
US20040028804A1
(en)
*
|
2002-08-07 |
2004-02-12 |
Anderson Daniel G. |
Production of polymeric microarrays
|
US7563507B2
(en)
*
|
2002-08-16 |
2009-07-21 |
University Of Massachusetts |
Pyridine and related ligand compounds, functionalized nanoparticulate composites and methods of preparation
|
WO2004031732A2
(en)
|
2002-10-03 |
2004-04-15 |
The Board Of Trustees Of The University Of Arkansas |
Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical, and thermal stability, and methods of making the same
|
US20040161424A1
(en)
*
|
2002-10-08 |
2004-08-19 |
Xenoport |
Human organic solute transporters
|
US20040086432A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Labarge William J. |
Reformer, systems utilizing the reformer, and methods for operating the systems
|
US7094730B2
(en)
*
|
2002-10-31 |
2006-08-22 |
Delphi Technologies, Inc. |
Gas treatment device, methods for making and using the same, and a vehicle exhaust system
|
EP1576138B1
(en)
|
2002-11-15 |
2017-02-01 |
Idenix Pharmaceuticals LLC. |
2'-methyl nucleosides in combination with interferon and flaviviridae mutation
|
US7560160B2
(en)
|
2002-11-25 |
2009-07-14 |
Materials Modification, Inc. |
Multifunctional particulate material, fluid, and composition
|
US8420086B2
(en)
|
2002-12-13 |
2013-04-16 |
Immunomedics, Inc. |
Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
|
US7007972B1
(en)
|
2003-03-10 |
2006-03-07 |
Materials Modification, Inc. |
Method and airbag inflation apparatus employing magnetic fluid
|
US20040185108A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Short Robert E. |
Method of preparing gas-filled polymer matrix microparticles useful for delivering drug
|
US7645512B1
(en)
*
|
2003-03-31 |
2010-01-12 |
The Research Foundation Of The State University Of New York |
Nano-structure enhancements for anisotropic conductive adhesive and thermal interposers
|
US8518304B1
(en)
|
2003-03-31 |
2013-08-27 |
The Research Foundation Of State University Of New York |
Nano-structure enhancements for anisotropic conductive material and thermal interposers
|
WO2004089345A1
(en)
*
|
2003-04-03 |
2004-10-21 |
Semafore Pharmaceuticals Inc. |
Bone targeting of biodegradable drug-containing nanoparticles
|
ATE539674T1
(en)
*
|
2003-04-24 |
2012-01-15 |
Univ Texas |
NON-INVASIVE BLOOD ANALYSIS BY OPTICAL PROBING OF THE VEINS UNDER THE TONGUE
|
US20040224030A1
(en)
*
|
2003-05-06 |
2004-11-11 |
Shastri Venkatram R. |
Microsphere delivery systems
|
US6982501B1
(en)
|
2003-05-19 |
2006-01-03 |
Materials Modification, Inc. |
Magnetic fluid power generator device and method for generating power
|
US7723311B2
(en)
*
|
2003-06-18 |
2010-05-25 |
Nanobiomagnetics, Inc. |
Delivery of bioactive substances to target cells
|
US8651113B2
(en)
*
|
2003-06-18 |
2014-02-18 |
Swr&D Inc. |
Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
|
US7344491B1
(en)
|
2003-11-26 |
2008-03-18 |
Nanobiomagnetics, Inc. |
Method and apparatus for improving hearing
|
US20040258614A1
(en)
*
|
2003-06-20 |
2004-12-23 |
University Of Maryland, Baltimore |
Microparticles for microarterial imaging and radiotherapy
|
ES2226567B1
(en)
*
|
2003-06-20 |
2006-07-01 |
Universidad De Santiago De Compostela |
NANOPARTICULAS OF HIALURONIC ACID.
|
WO2005002643A2
(en)
*
|
2003-06-24 |
2005-01-13 |
Johns Hopkins University |
Method and products for delivering biological molecules to cells using multicomponent nanostructures
|
ES2232287B1
(en)
*
|
2003-07-04 |
2006-11-01 |
Advanced In Vitro Cell Technologies, S.L. |
POLYOXYETHYLATE DERIVATIVES NANOPARTICLES.
|
US7200956B1
(en)
|
2003-07-23 |
2007-04-10 |
Materials Modification, Inc. |
Magnetic fluid cushioning device for a footwear or shoe
|
US7790141B2
(en)
*
|
2003-08-11 |
2010-09-07 |
Pathak Holdings, Llc |
Radio-opaque compounds, compositions containing same and methods of their synthesis and use
|
US20050042298A1
(en)
*
|
2003-08-20 |
2005-02-24 |
Pardridge William M. |
Immunonanoparticles
|
US20050136536A1
(en)
*
|
2003-09-15 |
2005-06-23 |
Anderson Daniel G. |
Embryonic epithelial cells
|
US7448389B1
(en)
|
2003-10-10 |
2008-11-11 |
Materials Modification, Inc. |
Method and kit for inducing hypoxia in tumors through the use of a magnetic fluid
|
US20050084513A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Board Of Regents |
Nanocoating for improving biocompatibility of medical implants
|
EP1677738A2
(en)
|
2003-10-31 |
2006-07-12 |
Point Biomedical Corporation |
Reconstitutable microsphere compositions useful as ultrasonic contrast agents
|
US7608240B2
(en)
*
|
2003-12-05 |
2009-10-27 |
Board Of Trustees Of The University Of Arkansas |
Nanotubes for cancer therapy and diagnostics
|
WO2005061724A1
(en)
*
|
2003-12-10 |
2005-07-07 |
The General Hospital Corporation |
Self-assembling nanoparticle conjugates
|
WO2005072710A2
(en)
*
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
JP2007520555A
(en)
*
|
2004-02-05 |
2007-07-26 |
バクスター・インターナショナル・インコーポレイテッド |
Dispersants prepared by use of self-stabilizing agents
|
US9550838B2
(en)
|
2004-02-13 |
2017-01-24 |
Ibc Pharmaceuticals, Inc. |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
|
US8883160B2
(en)
*
|
2004-02-13 |
2014-11-11 |
Ibc Pharmaceuticals, Inc. |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
|
US7632784B2
(en)
*
|
2004-04-17 |
2009-12-15 |
Rokhvarger Anatoly E |
Sintered ceramic composite lead with superconductive nano-architecture
|
ES2246695B1
(en)
*
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
STIMULATING COMPOSITION OF THE IMMUNE RESPONSE THAT INCLUDES NANOPARTICLES BASED ON A COPYLIMER OF METHYL VINYL ETER AND MALEIC ANHYDRIDE.
|
ES2246694B1
(en)
*
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
PEGILATED NANOPARTICLES.
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
WO2006004774A2
(en)
*
|
2004-06-28 |
2006-01-12 |
Stanford University |
Laulimalide analogues as therapeutic agents
|
EP1768692B8
(en)
*
|
2004-07-01 |
2015-06-17 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
WO2006085987A2
(en)
|
2004-07-09 |
2006-08-17 |
University Of Iowa Research Foundation |
Rna interference in respiratory epitheial cells
|
US20080299205A1
(en)
*
|
2004-07-19 |
2008-12-04 |
Mayer Lawrence D |
Particulate Constructs For Release of Active Agents
|
US8357391B2
(en)
|
2004-07-30 |
2013-01-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
|
EP1812494A1
(en)
*
|
2004-09-29 |
2007-08-01 |
Alza Corporation |
Microparticles and nanoparticles containing a lipopolymer
|
WO2007001448A2
(en)
*
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US20060198891A1
(en)
*
|
2004-11-29 |
2006-09-07 |
Francois Ravenelle |
Solid formulations of liquid biologically active agents
|
WO2006078725A1
(en)
*
|
2005-01-20 |
2006-07-27 |
Massachusetts Institute Of Technology |
Soft polylactides
|
US7611494B2
(en)
*
|
2005-02-08 |
2009-11-03 |
Confluent Surgical, Inc. |
Spray for fluent materials
|
WO2006094192A2
(en)
|
2005-03-03 |
2006-09-08 |
Immunomedics, Inc. |
Humanized l243 antibodies
|
US10058621B2
(en)
|
2015-06-25 |
2018-08-28 |
Immunomedics, Inc. |
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers
|
US9707302B2
(en)
|
2013-07-23 |
2017-07-18 |
Immunomedics, Inc. |
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
|
WO2006106513A2
(en)
*
|
2005-04-05 |
2006-10-12 |
Bar-Ilan University |
New core and core-shell nanoparticles containing iodine for x-ray imaging
|
US8349332B2
(en)
|
2005-04-06 |
2013-01-08 |
Ibc Pharmaceuticals, Inc. |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
|
US8475794B2
(en)
|
2005-04-06 |
2013-07-02 |
Ibc Pharmaceuticals, Inc. |
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
|
KR100806669B1
(en)
|
2005-06-23 |
2008-02-26 |
김정환 |
Nanoparticle-Biological Material Complex
|
JP2009502261A
(en)
*
|
2005-07-25 |
2009-01-29 |
ナノテクノロジー ビクトリア ピーティーワイ リミテッド |
Microarray device
|
US20100272769A1
(en)
*
|
2005-08-03 |
2010-10-28 |
Amcol International |
Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
|
US20080184618A1
(en)
*
|
2005-08-03 |
2008-08-07 |
Amcol International |
Virus-Interacting Layered Phyllosilicates and Methods of Use
|
US20070031512A1
(en)
*
|
2005-08-03 |
2007-02-08 |
Amcol International Corporation |
Virus-interacting layered phyllosilicates and methods of inactivating viruses
|
JP5295769B2
(en)
*
|
2005-08-31 |
2013-09-18 |
ティツー・バイオシステムズ・インコーポレーテッド |
NMR apparatus for detecting analytes
|
KR100718329B1
(en)
*
|
2005-09-08 |
2007-05-14 |
광주과학기술원 |
Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release, and method of preparing the same
|
US20070248675A1
(en)
*
|
2005-09-08 |
2007-10-25 |
Gwangju Institute Of Science And Technology |
Composite comprising polysaccharide-functionalized nanoparticle and hydrogel matrix, a drug delivery system and a bone defect replacement matrix for sustained release comprising the same, and the preparation method thereof
|
US20070264199A1
(en)
*
|
2005-09-26 |
2007-11-15 |
Labhasetwar Vinod D |
Magnetic nanoparticle composition and methods for using the same
|
US20070071683A1
(en)
*
|
2005-09-27 |
2007-03-29 |
The Regents Of The University Of California |
Ultrasonic concentration of carrier particles
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
EP2674440B1
(en)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Multivalent immunoglobulin-based bioactive assemblies
|
US20070156230A1
(en)
|
2006-01-04 |
2007-07-05 |
Dugan Stephen R |
Stents with radiopaque markers
|
EP1986702A4
(en)
*
|
2006-02-21 |
2012-12-12 |
Avrum Belzer |
Hyperpolarization methods, systems and compositions
|
US8021689B2
(en)
*
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
AU2013205838B2
(en)
*
|
2006-02-21 |
2016-03-17 |
Avrum Belzer |
Hyperpolarization Methods, Systems and Compositions
|
KR100819378B1
(en)
*
|
2006-02-24 |
2008-04-04 |
(주)에이티젠 |
Magnetic nanocomposite using amphiphilic compound and pharmaceutical composition comprising the same
|
US20070218007A1
(en)
*
|
2006-03-17 |
2007-09-20 |
Allergan, Inc. |
Ophthalmic visualization compositions and methods of using same
|
US20070225472A1
(en)
*
|
2006-03-23 |
2007-09-27 |
Varshney Sunil K |
Polyanhydride polymers and their uses in biomedical devices
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
CA2652280C
(en)
|
2006-05-15 |
2014-01-28 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
US8752268B2
(en)
|
2006-05-26 |
2014-06-17 |
Abbott Cardiovascular Systems Inc. |
Method of making stents with radiopaque markers
|
KR20090024242A
(en)
|
2006-06-06 |
2009-03-06 |
루트거스, 더 스테이트 유니버시티 오브 뉴 저지 |
Iodinated polymers
|
US8535372B1
(en)
|
2006-06-16 |
2013-09-17 |
Abbott Cardiovascular Systems Inc. |
Bioabsorbable stent with prohealing layer
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
US8128688B2
(en)
|
2006-06-27 |
2012-03-06 |
Abbott Cardiovascular Systems Inc. |
Carbon coating on an implantable device
|
US7823263B2
(en)
|
2006-07-11 |
2010-11-02 |
Abbott Cardiovascular Systems Inc. |
Method of removing stent islands from a stent
|
EP3009477B1
(en)
|
2006-07-20 |
2024-01-24 |
Orbusneich Medical Pte. Ltd |
Bioabsorbable polymeric composition for a medical device
|
US8016879B2
(en)
|
2006-08-01 |
2011-09-13 |
Abbott Cardiovascular Systems Inc. |
Drug delivery after biodegradation of the stent scaffolding
|
EP2057987B1
(en)
*
|
2006-08-30 |
2015-03-04 |
Kyushu University, National University Corporation |
Pharmaceutical composition containing statin-encapsulated nanoparticle
|
WO2008030557A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Johns Hopkins University |
Compositions and methods for enhancing transport through mucus
|
KR100946275B1
(en)
*
|
2006-09-26 |
2010-03-08 |
주식회사 삼양사 |
Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
|
US7959942B2
(en)
|
2006-10-20 |
2011-06-14 |
Orbusneich Medical, Inc. |
Bioabsorbable medical device with coating
|
EP2073754A4
(en)
|
2006-10-20 |
2012-09-26 |
Orbusneich Medical Inc |
Bioabsorbable polymeric composition and medical device background
|
CA2667325A1
(en)
*
|
2006-10-23 |
2008-05-02 |
Bioabsorbable Therapeutics, Inc. |
A drug-release composition having a therapeutic carrier
|
WO2008084286A2
(en)
|
2006-10-25 |
2008-07-17 |
Arterial Remodeling Technologies, S.A. |
Method for expansion and deployment of polymeric structures including stents
|
US11712510B2
(en)
|
2006-11-27 |
2023-08-01 |
Frank Levy |
Delivery system and method for the effective, reliable and foolproof delivery of controlled amounts of a medical fluid
|
US10149935B2
(en)
*
|
2006-11-27 |
2018-12-11 |
Frank Levy |
Delivery system and method for the effective and reliable delivery of controlled amounts of a medical fluid
|
WO2008091465A2
(en)
*
|
2006-12-21 |
2008-07-31 |
Wayne State University |
Peg and targeting ligands on nanoparticle surface
|
KR100809402B1
(en)
|
2007-01-29 |
2008-03-05 |
김정환 |
Nanoparticle mark, diagnosis kit using the same and diagnosis method using the same
|
GB0701896D0
(en)
|
2007-02-01 |
2007-03-14 |
Regentec Ltd |
Composition
|
EP2134830A2
(en)
|
2007-02-09 |
2009-12-23 |
Massachusetts Institute of Technology |
Oscillating cell culture bioreactor
|
US10265407B2
(en)
|
2007-02-15 |
2019-04-23 |
Yale University |
Modular nanodevices for smart adaptable vaccines
|
US8889117B2
(en)
|
2007-02-15 |
2014-11-18 |
Yale University |
Modular nanoparticles for adaptable vaccines
|
WO2008124639A2
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
US8309129B2
(en)
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
WO2008135855A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
EP2431043A1
(en)
|
2007-05-23 |
2012-03-21 |
Amcol International Corporation |
Cholesterol-interacting layered phyllosilicates for suppressing gastrointestinal cholesterol absorption
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
EP2162120B1
(en)
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
US7901452B2
(en)
|
2007-06-27 |
2011-03-08 |
Abbott Cardiovascular Systems Inc. |
Method to fabricate a stent having selected morphology to reduce restenosis
|
US7955381B1
(en)
|
2007-06-29 |
2011-06-07 |
Advanced Cardiovascular Systems, Inc. |
Polymer-bioceramic composite implantable medical device with different types of bioceramic particles
|
US9125807B2
(en)
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
US8268638B2
(en)
|
2007-07-18 |
2012-09-18 |
Advantageous Systems, Llc |
Methods and apparatuses for detecting analytes in biological fluid of an animal
|
WO2009026164A1
(en)
*
|
2007-08-17 |
2009-02-26 |
The General Hospital Corporation |
Magnetic resonance-based viscometers and methods
|
SG150405A1
(en)
*
|
2007-08-29 |
2009-03-30 |
Agency Science Tech & Res |
Method of coating a particle
|
EP2436376B1
(en)
|
2007-09-28 |
2014-07-09 |
BIND Therapeutics, Inc. |
Cancer cell targeting using nanoparticles
|
ES2627292T3
(en)
|
2007-10-12 |
2017-07-27 |
Massachusetts Institute Of Technology |
Vaccine Nanotechnology
|
WO2009073215A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
WO2009073216A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
|
WO2009110939A2
(en)
*
|
2007-12-10 |
2009-09-11 |
Massachusetts Institute Of Technology |
Drug delivery system for pharmaceuticals and radiation
|
JP5502751B2
(en)
|
2007-12-20 |
2014-05-28 |
エボニック コーポレイション |
Process for preparing microparticles with low residual solvent concentration
|
CN102105554A
(en)
*
|
2008-06-10 |
2011-06-22 |
阿肯色大学托管委员会 |
Indium arsenide nanocrystals and methods of making the same
|
EP2309990B2
(en)
|
2008-06-16 |
2017-03-15 |
Pfizer Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
ES2721850T3
(en)
*
|
2008-06-16 |
2019-08-05 |
Pfizer |
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of manufacturing and using them
|
US8613951B2
(en)
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
US20100055041A1
(en)
*
|
2008-08-28 |
2010-03-04 |
Dong June Ahn |
Nanotracer for in-situ gastric cancer detection
|
WO2010039865A2
(en)
*
|
2008-10-01 |
2010-04-08 |
Cornell University |
Biodegradable chemical delivery system
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
JP2012512175A
(en)
*
|
2008-12-15 |
2012-05-31 |
バインド バイオサイエンシズ インコーポレイテッド |
Long-circulating nanoparticles for sustained release of therapeutic agents
|
CA2750242C
(en)
|
2009-02-12 |
2018-05-22 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
US8580230B2
(en)
*
|
2009-02-23 |
2013-11-12 |
Kent State University |
Materials and methods for MRI contrast agents and drug delivery
|
WO2010117668A1
(en)
*
|
2009-03-30 |
2010-10-14 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
WO2010117957A2
(en)
*
|
2009-04-06 |
2010-10-14 |
Mayo Foundation For Medical Education And Research |
Methods and materials for delivering molecules
|
AU2010254551B2
(en)
|
2009-05-27 |
2016-10-20 |
Selecta Biosciences, Inc. |
Immunomodulatory agent-polymeric compounds
|
BR112012003977A2
(en)
|
2009-08-26 |
2017-06-06 |
Selecta Biosciences Inc |
t-cell aid-inducing compositions
|
US9205155B2
(en)
|
2009-10-30 |
2015-12-08 |
General Electric Company |
Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents
|
US8357401B2
(en)
|
2009-12-11 |
2013-01-22 |
Bind Biosciences, Inc. |
Stable formulations for lyophilizing therapeutic particles
|
WO2011084518A2
(en)
|
2009-12-15 |
2011-07-14 |
Bind Biosciences, Inc. |
Therapeutic polymeric nanoparticles comprising corticosteroids and methods of making and using same
|
ES2780156T3
(en)
|
2009-12-15 |
2020-08-24 |
Pfizer |
Therapeutic compositions of polymeric nanoparticles with high glass transition temperature or high molecular weight copolymers
|
IN2012DN05177A
(en)
|
2009-12-15 |
2015-10-23 |
Incept Llc |
|
EA201290506A1
(en)
*
|
2009-12-16 |
2013-03-29 |
Брихэм Энд Уимен'З Хоспитал, Инк. |
PARTICLES FOR DELIVERY OF A SET OF AGENTS
|
WO2011075516A2
(en)
|
2009-12-18 |
2011-06-23 |
President And Fellows Of Harvard College |
Active scaffolds for on-demand drug and cell delivery
|
EP2523680A4
(en)
*
|
2010-01-11 |
2013-06-19 |
Ct Molecular Med & Immunology |
Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma
|
US8568471B2
(en)
|
2010-01-30 |
2013-10-29 |
Abbott Cardiovascular Systems Inc. |
Crush recoverable polymer scaffolds
|
US8808353B2
(en)
|
2010-01-30 |
2014-08-19 |
Abbott Cardiovascular Systems Inc. |
Crush recoverable polymer scaffolds having a low crossing profile
|
US8889193B2
(en)
|
2010-02-25 |
2014-11-18 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
US20110236496A1
(en)
*
|
2010-03-26 |
2011-09-29 |
Peter Markland |
Emulsions for Microencapsulation Comprising Biodegradable Surface-Active Block Copolymers as Stabilizers
|
US8808357B2
(en)
*
|
2010-04-06 |
2014-08-19 |
Poly-Med, Inc. |
Radiopaque iodinated and iodide-containing crystalline absorbable aliphatic polymeric materials and applications thereof
|
CA2798323A1
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Dose selection of adjuvanted synthetic nanocarriers
|
US9364568B2
(en)
*
|
2010-07-15 |
2016-06-14 |
Warsaw Orthopedic, Inc. |
Methods to diagnose degenerative disc disease
|
AU2011291586A1
(en)
*
|
2010-08-20 |
2013-03-07 |
Cerulean Pharma Inc. |
Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
|
KR20130100290A
(en)
|
2010-08-30 |
2013-09-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Shear controlled release for stenotic lesions and thrombolytic therapies
|
WO2012039979A2
(en)
|
2010-09-10 |
2012-03-29 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
US9782342B2
(en)
|
2010-10-11 |
2017-10-10 |
Wichita State University |
Composite magnetic nanoparticle drug delivery system
|
US9714940B2
(en)
|
2010-10-22 |
2017-07-25 |
T2 Biosystems, Inc. |
NMR systems and methods for the rapid detection of analytes
|
US8563298B2
(en)
|
2010-10-22 |
2013-10-22 |
T2 Biosystems, Inc. |
NMR systems and methods for the rapid detection of analytes
|
US8409807B2
(en)
|
2010-10-22 |
2013-04-02 |
T2 Biosystems, Inc. |
NMR systems and methods for the rapid detection of analytes
|
US9994443B2
(en)
|
2010-11-05 |
2018-06-12 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
MA34832B1
(en)
|
2010-12-29 |
2014-01-02 |
Medincell |
BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
|
WO2012105984A1
(en)
*
|
2011-02-04 |
2012-08-09 |
Empire Technology Development Llc |
Materials, monitoring, and controlling tissue growth using magnetic nanoparticles
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
US9713702B2
(en)
*
|
2011-03-14 |
2017-07-25 |
The Board Of Trustee Of The Leland Stanford Junior University |
Methods of electric field induced delivery of compounds, compositions used in delivery, and systems of delivery
|
US9801829B2
(en)
*
|
2011-04-29 |
2017-10-31 |
University Of Florida Research Foundation, Inc. |
Methods and systems of making nanostructures
|
CN103517707A
(en)
|
2011-04-29 |
2014-01-15 |
西莱克塔生物科技公司 |
Controlled release of immunosuppressants from synthetic nanocarriers
|
RU2013154422A
(en)
*
|
2011-05-09 |
2015-06-20 |
Институт Кимик Де Саррия |
POLYMERIC NANOPARTICLES INTENDED FOR DELIVERY OF MEDICINES
|
EP2734843A2
(en)
|
2011-07-18 |
2014-05-28 |
President and Fellows of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
US20130028857A1
(en)
|
2011-07-29 |
2013-01-31 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents
|
US8726483B2
(en)
|
2011-07-29 |
2014-05-20 |
Abbott Cardiovascular Systems Inc. |
Methods for uniform crimping and deployment of a polymer scaffold
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
WO2013082476A1
(en)
|
2011-11-30 |
2013-06-06 |
Emory University |
Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
|
CA2853138A1
(en)
|
2011-12-05 |
2013-06-13 |
Immunomedics, Inc. |
Therapeutic use of anti-cd22 antibodies for inducing trogocytosis
|
US9757458B2
(en)
|
2011-12-05 |
2017-09-12 |
Immunomedics, Inc. |
Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells
|
EP2804632B1
(en)
|
2012-01-19 |
2019-09-18 |
The Johns Hopkins University |
Nanoparticle formulations with enhanced mucosal penetration
|
US8927529B2
(en)
|
2012-01-30 |
2015-01-06 |
SpineThera |
Treatment of back pain by injection of microparticles of dexamethasone acetate and a polymer
|
US20130236504A1
(en)
|
2012-03-06 |
2013-09-12 |
Medical University Of South Carolina |
Delivery System for Enhancing Drug Efficacy
|
EA030318B1
(en)
|
2012-03-16 |
2018-07-31 |
Дзе Джонс Хопкинс Юниверсити |
Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
|
JP5883539B2
(en)
*
|
2012-03-16 |
2016-03-15 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
Controlled release formulations for delivery of HIF-1 inhibitors
|
US9562271B2
(en)
|
2012-04-20 |
2017-02-07 |
T2 Biosystems, Inc. |
Compositions and methods for detection of Candida species
|
EP2841098A4
(en)
|
2012-04-23 |
2016-03-02 |
Allertein Therapeutics Llc |
Nanoparticles for treatment of allergy
|
CA2871745C
(en)
|
2012-05-03 |
2023-01-24 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
KR102140989B1
(en)
|
2012-05-03 |
2020-08-04 |
칼라 파마슈티컬스, 인크. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
AU2013256008B2
(en)
|
2012-05-04 |
2016-02-25 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
US9533068B2
(en)
|
2012-05-04 |
2017-01-03 |
The Johns Hopkins University |
Drug loaded microfiber sutures for ophthalmic application
|
BR112015005940A2
(en)
|
2012-09-17 |
2017-07-04 |
Bind Therapeutics Inc |
process for the preparation of therapeutic nanoparticles
|
CN103830741B
(en)
*
|
2012-11-27 |
2019-02-19 |
杨子剑 |
Compound and preparation method and purposes containing tazatide analog structure
|
CN103848901A
(en)
*
|
2012-11-28 |
2014-06-11 |
杨子剑 |
New compound containing vancomycin structure as well as preparation method and application thereof
|
CN103848986B
(en)
*
|
2012-11-28 |
2019-10-11 |
杨子剑 |
Compound and preparation method and purposes containing cephalosporin structure
|
CN103848894A
(en)
*
|
2012-11-30 |
2014-06-11 |
杨子剑 |
Novel compound containing daptomycin structure as well as preparation method and application thereof
|
US10137196B2
(en)
|
2012-12-13 |
2018-11-27 |
Immunomedics, Inc. |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
|
PT2900277T
(en)
|
2012-12-13 |
2022-05-25 |
Immunomedics Inc |
Dosages of immunoconjugates of antibodies and sn-38 for improved efficacy and decreased toxicity
|
US9492566B2
(en)
|
2012-12-13 |
2016-11-15 |
Immunomedics, Inc. |
Antibody-drug conjugates and uses thereof
|
US9931417B2
(en)
|
2012-12-13 |
2018-04-03 |
Immunomedics, Inc. |
Antibody-SN-38 immunoconjugates with a CL2A linker
|
US10413539B2
(en)
|
2012-12-13 |
2019-09-17 |
Immunomedics, Inc. |
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)
|
US10206918B2
(en)
|
2012-12-13 |
2019-02-19 |
Immunomedics, Inc. |
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers
|
ES2819573T3
(en)
|
2012-12-13 |
2021-04-16 |
Immunomedics Inc |
Method for Producing Antibody-SN-38 Immunoconjugates with a CL2A Linker
|
US10744129B2
(en)
|
2012-12-13 |
2020-08-18 |
Immunomedics, Inc. |
Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2
|
US10568975B2
(en)
|
2013-02-05 |
2020-02-25 |
The Johns Hopkins University |
Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
|
US9468681B2
(en)
|
2013-03-01 |
2016-10-18 |
California Institute Of Technology |
Targeted nanoparticles
|
WO2014144325A1
(en)
|
2013-03-15 |
2014-09-18 |
President And Fellows Of Harvard College |
Methods and compositions for improving detection and/or capture of a target entity
|
MX2015013894A
(en)
|
2013-04-03 |
2015-12-11 |
Allertein Therapeutics Llc |
Novel nanoparticle compositions.
|
KR20220025909A
(en)
|
2013-05-03 |
2022-03-03 |
셀렉타 바이오사이언시즈, 인크. |
Delivery of immunosuppressants having a specified pharmacodynamic effective-life and antigen for the inducation of immune tolerance
|
CA2913155A1
(en)
|
2013-05-21 |
2014-11-27 |
President And Fellows Of Harvard College |
Engineered heme-binding compositions and uses thereof
|
KR102631173B1
(en)
|
2013-06-04 |
2024-01-31 |
셀렉타 바이오사이언시즈, 인크. |
Repeated administration of non-immunosupressive antigen specific immunotherapeutics
|
US11253606B2
(en)
|
2013-07-23 |
2022-02-22 |
Immunomedics, Inc. |
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, Bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
|
CN105037710A
(en)
*
|
2013-09-01 |
2015-11-11 |
韩冰 |
Preparation method of new compound and new application of the compound in medical treatment
|
MX370490B
(en)
|
2013-09-16 |
2019-12-16 |
Astrazeneca Ab |
Therapeutic polymeric nanoparticles and methods of making and using same.
|
EP3546474B1
(en)
|
2013-12-18 |
2021-07-07 |
President and Fellows of Harvard College |
Crp capture/detection of gram positive bacteria
|
WO2015127368A1
(en)
|
2014-02-23 |
2015-08-27 |
The Johns Hopkins University |
Hypotonic microbicidal formulations and methods of use
|
MX2016012009A
(en)
|
2014-03-14 |
2016-12-05 |
Pfizer |
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same.
|
WO2015175545A1
(en)
|
2014-05-12 |
2015-11-19 |
The Johns Hopkins University |
Highly stable biodegradable gene vector platforms for overcoming biological barriers
|
AU2015274334B2
(en)
|
2014-06-12 |
2020-12-17 |
Cedars-Sinai Medical Center |
Compositions and methods for treating cancers
|
WO2015200054A2
(en)
|
2014-06-24 |
2015-12-30 |
The Trustees Of Princeton University |
Process for encapsulating soluble biologics, therapeutics, and imaging agents
|
WO2015200728A1
(en)
|
2014-06-25 |
2015-12-30 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
EP3190417A4
(en)
|
2014-09-02 |
2018-04-18 |
LSI Medience Corporation |
Polymer microparticle for carrying physiologically active substance and method for preparing same
|
BR112017001470A2
(en)
|
2014-09-07 |
2018-02-20 |
Selecta Biosciences Inc |
methods and compositions for attenuating the immune responses of the gene therapy antiviral transfer vector
|
FI3834823T3
(en)
|
2014-11-05 |
2024-04-02 |
Cartesian Therapeutics Inc |
Methods and compositions related to the use of low hlb surfactants in the production of synthetic nanocarriers comprising a rapalog
|
SG10201903210WA
(en)
|
2014-12-15 |
2019-05-30 |
Univ Johns Hopkins |
Sunitinib Formulations and Methods for Use Thereof in Treatment of Ocular Disorders
|
US10485757B2
(en)
|
2015-01-27 |
2019-11-26 |
The Johns Hopkins University |
Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
|
US9999527B2
(en)
|
2015-02-11 |
2018-06-19 |
Abbott Cardiovascular Systems Inc. |
Scaffolds having radiopaque markers
|
US9737368B2
(en)
|
2015-02-24 |
2017-08-22 |
Abbott Cardiovascular Systems Inc. |
System and method for attaching a radiopaque marker bead to an endoprosthesis
|
CA2981543A1
(en)
|
2015-04-22 |
2016-10-27 |
Immunomedics, Inc. |
Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
|
US9700443B2
(en)
|
2015-06-12 |
2017-07-11 |
Abbott Cardiovascular Systems Inc. |
Methods for attaching a radiopaque marker to a scaffold
|
US10195175B2
(en)
|
2015-06-25 |
2019-02-05 |
Immunomedics, Inc. |
Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors
|
EP3317323B1
(en)
|
2015-07-01 |
2021-05-26 |
California Institute of Technology |
Cationic mucic acid polymer-based delivery systems
|
US10435457B2
(en)
|
2015-08-06 |
2019-10-08 |
President And Fellows Of Harvard College |
Microbe-binding molecules and uses thereof
|
AR106018A1
(en)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS
|
ES2908479T3
(en)
|
2015-08-26 |
2022-04-29 |
Achillion Pharmaceuticals Inc |
Compounds for the treatment of immune and inflammatory disorders
|
EP3368008A1
(en)
*
|
2015-10-30 |
2018-09-05 |
The Johns Hopkins University |
Mucus penetrating particles with high molecular weight and dense coatings
|
JP2018533596A
(en)
|
2015-11-12 |
2018-11-15 |
グレイバグ ビジョン インコーポレイテッド |
Aggregated microparticles for medical therapy
|
CA3004849A1
(en)
|
2015-11-16 |
2017-05-26 |
Georges Gaudriault |
A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
|
US11103461B2
(en)
|
2015-12-22 |
2021-08-31 |
The Trustees Of Princeton University |
Process for encapsulating soluble biologics, therapeutics, and imaging agents
|
US11519016B2
(en)
|
2016-01-21 |
2022-12-06 |
T2 Biosystems, Inc. |
NMR methods and systems for the rapid detection of bacteria
|
CA3011372A1
(en)
|
2016-02-10 |
2017-08-17 |
Immunomedics, Inc. |
Combination of abcg2 inhibitors with sacituzumab govitecan (immu-132) overcomes resistance to sn-38 in trop-2 expressing cancers
|
US11484591B2
(en)
|
2016-02-22 |
2022-11-01 |
Ohio State Innovation Foundation |
Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin A analogues or metabolites, and estradiol metabolites
|
CN109152819A
(en)
|
2016-03-11 |
2019-01-04 |
西莱克塔生物科技公司 |
The preparation and dosage of Pegylation uricase
|
CN105859933B
(en)
*
|
2016-03-31 |
2018-09-21 |
北京化工大学 |
A kind of response type polymer microballoon and its preparation method and application with nucleocapsid
|
CN109310385A
(en)
|
2016-04-27 |
2019-02-05 |
免疫医疗公司 |
Anti- TROP-2-SN-38 antibody drug conjugate is used for the effect of checkpoint inhibitor recurrence/refractory tumors therapy
|
WO2017197046A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
C3-carbon linked glutarimide degronimers for target protein degradation
|
CN109562113A
(en)
|
2016-05-10 |
2019-04-02 |
C4医药公司 |
Loop coil degron body for target protein degradation
|
EP3454856A4
(en)
|
2016-05-10 |
2019-12-25 |
C4 Therapeutics, Inc. |
Heterocyclic degronimers for target protein degradation
|
RU2018145364A
(en)
|
2016-06-27 |
2020-07-28 |
Ачиллион Фармасьютикалс, Инк. |
QUINAZOLINE AND INDOLE COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS
|
JP2019520379A
(en)
|
2016-07-01 |
2019-07-18 |
ジー1 セラピューティクス, インコーポレイテッド |
Pyrimidine antiproliferative agents
|
WO2018064215A1
(en)
|
2016-09-27 |
2018-04-05 |
Selecta Biosciences, Inc. |
Recombinant immunotoxins for use in the treatment of cancer
|
EP3541391A4
(en)
|
2016-11-17 |
2020-06-17 |
The University of North Carolina at Chapel Hill |
Alkyl pyrrolopyrimidine analogs and methods of making and using same
|
US20180193482A1
(en)
|
2017-01-07 |
2018-07-12 |
Selecta Biosciences, Inc. |
Patterned dosing of immunosuppressants coupled to synthetic nanocarriers
|
CN110612122A
(en)
|
2017-03-11 |
2019-12-24 |
西莱克塔生物科技公司 |
Methods and compositions related to combination therapy with anti-inflammatory agents and synthetic nanocarriers comprising immunosuppressants
|
WO2018175922A1
(en)
|
2017-03-23 |
2018-09-27 |
Graybug Vision, Inc. |
Drugs and compositions for the treatment of ocular disorders
|
EP3600283A4
(en)
|
2017-03-27 |
2020-12-16 |
Immunomedics, Inc. |
Treatment of trop-2 expressing triple negative breast cancer with sacituzumab govitecan and a rad51 inhibitor
|
CN110352201A
(en)
|
2017-04-03 |
2019-10-18 |
免疫医疗公司 |
The subcutaneous administration of antibody drug conjugate for cancer therapy
|
JP2020519585A
(en)
|
2017-05-10 |
2020-07-02 |
グレイバグ ビジョン インコーポレイテッド |
Extended release microparticles and suspensions thereof for medical therapy
|
WO2019055539A1
(en)
|
2017-09-12 |
2019-03-21 |
Prudhomme Robert K |
Cellulosic polymer nanoparticles and methods of forming them
|
US20190112731A1
(en)
|
2017-10-12 |
2019-04-18 |
Julianne Holloway |
Manufacturing gradient materials using magnetically-assisted electrospinning
|
MX2020003838A
(en)
|
2017-10-13 |
2020-08-06 |
Selecta Biosciences Inc |
Methods and compositions for attenuating anti-viral transfer vector igm responses.
|
EP3470056B1
(en)
|
2017-10-16 |
2022-04-27 |
Medtronic Vascular Inc. |
Therapeutic nanoparticles for treating vascular diseases
|
EP3773576A4
(en)
|
2018-03-26 |
2021-12-29 |
C4 Therapeutics, Inc. |
Cereblon binders for the degradation of ikaros
|
EP3823676A1
(en)
|
2018-07-16 |
2021-05-26 |
Selecta Biosciences, Inc. |
Methods and compositions of mma constructs and vectors
|
BR112021000763A2
(en)
|
2018-07-16 |
2021-04-13 |
Selecta Biosciences, Inc. |
OTC CONSTRUCTION AND VECTOR METHODS AND COMPOSITIONS
|
US11731099B2
(en)
|
2018-07-20 |
2023-08-22 |
The Trustees Of Princeton University |
Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
|
EP3841086A4
(en)
|
2018-08-20 |
2022-07-27 |
Achillion Pharmaceuticals, Inc. |
Pharmaceutical compounds for the treatment of complement factor d medical disorders
|
CN113365617A
(en)
|
2018-10-16 |
2021-09-07 |
乔治亚州立大学研究基金会股份有限公司 |
Carbon monoxide prodrugs for the treatment of medical conditions
|
US10987315B1
(en)
|
2018-12-04 |
2021-04-27 |
University Of South Florida |
Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis
|
WO2020148206A1
(en)
|
2019-01-14 |
2020-07-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for generating and selecting a variant of a binding protein with increased binding affinity and/or specificity
|
WO2020223205A1
(en)
|
2019-04-28 |
2020-11-05 |
Selecta Biosciences, Inc. |
Methods for treatment of subjects with preexisting immunity to viral transfer vectors
|
US11471412B1
(en)
|
2019-05-10 |
2022-10-18 |
University Of South Florida |
Nanoparticles and nanogel drug compositions for treatment of age-related macular degeneration
|
BR112021023594A2
(en)
|
2019-05-28 |
2022-02-08 |
Selecta Biosciences Inc |
Methods and compositions for attenuated antiviral transfer vector immune response
|
EP3980784A1
(en)
|
2019-06-04 |
2022-04-13 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
WO2021081062A1
(en)
|
2019-10-21 |
2021-04-29 |
Selecta Biosciences, Inc. |
Methods and compositions for treating liver diseases and disorders
|
CA3160642A1
(en)
|
2019-11-08 |
2021-05-14 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
MX2022010568A
(en)
|
2020-02-26 |
2022-11-30 |
Selecta Biosciences Inc |
Methods and compositions using synthetic nanocarriers comprising immunosuppressant.
|
WO2021183781A1
(en)
|
2020-03-11 |
2021-09-16 |
Selecta Biosciences, Inc. |
Methods and compositions related to synthetic nanocarriers
|
CA3180166A1
(en)
|
2020-04-14 |
2021-10-21 |
Selecta Biosciences, Inc. |
Methods and compositions for inducing autophagy
|
KR20230088732A
(en)
|
2020-09-29 |
2023-06-20 |
옥스포드 유니버시티 이노베이션 리미티드 |
stroke treatment
|
AU2022206197A1
(en)
|
2021-01-05 |
2023-07-13 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
KR20230167405A
(en)
|
2021-04-09 |
2023-12-08 |
셀렉타 바이오사이언시즈, 인크. |
Synthetic nanocarriers containing immunosuppressants combined with high-affinity IL-2 receptor agonists to promote immune tolerance.
|
CA3235269A1
(en)
|
2021-10-12 |
2023-04-20 |
Cartesian Therapeutics, Inc. |
Viral vector dosing protocols
|
WO2023064367A1
(en)
|
2021-10-12 |
2023-04-20 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
WO2023086615A1
(en)
|
2021-11-14 |
2023-05-19 |
Selecta Biosciences, Inc. |
Multiple dosing with viral vectors
|
US20230263906A1
(en)
|
2022-01-10 |
2023-08-24 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and synthetic nanocarrier dose sparing
|
WO2023172628A1
(en)
|
2022-03-09 |
2023-09-14 |
Selecta Biosciences, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists and related dosing
|
WO2023172624A1
(en)
|
2022-03-09 |
2023-09-14 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
WO2023183568A1
(en)
|
2022-03-25 |
2023-09-28 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists and anti-igm agents
|
WO2023196566A1
(en)
|
2022-04-08 |
2023-10-12 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and immunosuppressants to enhance immune tolerance
|